Live Breaking News & Updates on Rug Lipid Lowering

Stay updated with breaking news from Rug lipid lowering . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Statin Use Remains Low for At-Risk Patients

Expanded prescribing guidelines have not boosted statin use among patients who are at risk for atherosclerotic cardiovascular disease. ....

United States , Timothys Anderson , Nutrition Examination , American Heart Association , National Health , American College Of Cardiology , University Of Pittsburgh , American College , Nutrition Examination Survey , General Internal Medicine , National Institute , National Institutes , Ipid Management , Diabetes Mellitus Type 2 , Iabetes Mellitus Type Ii , Type 2 Diabetes , Lipid Lowering Drugs , Rug Lipid Lowering , Atherosclerotic Heart Disease , Therosclerotic Cardiovascular Disease , Oronary Heart Disease , Schemic Heart Disease , Clinical Guidelines , Cardiovascular Disease , Vd Cardiovascular Disease ,

Pharmacist-Based Strategy Places More Patients on Statins

In two studies run in parallel, testing different strategies, automatic referral to a pharmacist was superior to EHR alerts for increasing statin prescriptions for at-risk patients. ....

United States , Alexanderc Faranoff , American Heart Association , Penn Medicine , Ipid Management , Lipid Lowering Drugs , Rug Lipid Lowering , Healthcare Technology , Ealth Care Technology , Electronic Medical Record Emr , Electronic Medical Record , Omputerized Medical Records Systems , Primary Care ,

Gaps Persist in Awareness, Treatment of High LDL-C

The prevalence of elevated low-density lipoprotein cholesterol has declined recently, but millions of Americans still have levels for which treatment is recommended or should be considered and many remain untreated. ....

United States , Al Qahirah , Ahmed Sayed , National Health , Research Letter , Ain Shams University , Nutrition Examination , Nutrition Examination Survey , Ipid Management , Low Ldl Cholesterol , Ow Low Density Lipoprotein Cholesterol , Preventive Screening , Primary Care , Social Determinants Of Health , Lipid Lowering Drugs , Rug Lipid Lowering ,

Another Study Ties Statins to T2D: Should Practice Change?

The latest study of statins and diabetes risk points to a small increased risk for new-onset diabetes with rosuvastatin vs atorvastatin, but experts advise caution in interpreting the results. ....

United States , Cleveland Clinic , New York , South Korea , Soult Ukpyolsi , Seth Shay Martin , Ishak Mansi , Steven Nissen , Jill Crandall , Eli Lilly , Byron Hoogwerf , American Diabetes Association , Lipid Disorders Program , Ciccarone Center , Drug Administration , Yonsei University College Of Medicine , Digital Health Lab , Orlando Va Health Care System , Department Of Endocrinology , Vascular Institute , Albert Einstein College Of Medicine , American Heart Association , Zealand Pharmaceuticals , Care System , Albert Einstein College , New York City ,

Next Up in MS Trials: More Insight Into Progressive Disease

Neurologist Jeremy Chataway brings you the latest on important clinical trials in progressive MS that will help guide the field toward better treatments. ....

United Kingdom , Jeremy Chataway , University College London , National Multiple Sclerosis Society , Health Technology Assessment , University College London Hospitals Biomedical Research Centers , United Kingdom Multiple Sclerosis Society , Veterans Administration , Queen Square Multiple Sclerosis Centre , Canadian Ms Society , National Institute Of Health Research , Mechanism Evaluation Board , Multiple Sclerosis Trials Collaboration , Rosetrees Trust , National Institute , Health Research Support , Multiple Sclerosis Ms , Multiple Sclerosis , Clinical Research , Clinical Trials , Linical Studies , Lipid Lowering Drugs , Rug Lipid Lowering , United Kingdom Site Content ,